These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2773937)

  • 1. Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.
    Koeberl DD; Bottema CD; Buerstedde JM; Sommer SS
    Am J Hum Genet; 1989 Sep; 45(3):448-57. PubMed ID: 2773937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.
    Koeberl DD; Bottema CD; Ketterling RP; Bridge PJ; Lillicrap DP; Sommer SS
    Am J Hum Genet; 1990 Aug; 47(2):202-17. PubMed ID: 2198809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.
    Ketterling RP; Vielhaber E; Sommer SS
    Am J Hum Genet; 1994 May; 54(5):831-5. PubMed ID: 8178822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.
    Bottema CD; Ketterling RP; Vielhaber E; Yoon HS; Gostout B; Jacobson DP; Shapiro A; Sommer SS
    Hum Genet; 1993 Jun; 91(5):496-503. PubMed ID: 8314564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians.
    Bottema CD; Ketterling RP; Yoon HS; Sommer SS
    Am J Hum Genet; 1990 Nov; 47(5):835-41. PubMed ID: 2220823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why does the human factor IX gene have a G + C content of 40%?
    Bottema CD; Bottema MJ; Ketterling RP; Yoon HS; Janco RL; Phillips JA; Sommer SS
    Am J Hum Genet; 1991 Oct; 49(4):839-50. PubMed ID: 1897528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.
    Chen SH; Zhang M; Lovrien EW; Scott CR; Thompson AR
    Hum Genet; 1991 Jun; 87(2):177-82. PubMed ID: 2066105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs.
    Koeberl DD; Bottema CD; Sarkar G; Ketterling RP; Chen SH; Sommer SS
    Hum Genet; 1990 Apr; 84(5):387-90. PubMed ID: 1969838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human factor IXLincoln Park: a molecular characterization.
    Rao KJ; Lyman G; Hamsbhushanam K; Scott JP; Jagadeeswaran P
    Mol Cell Probes; 1990 Oct; 4(5):335-40. PubMed ID: 1980717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene diagnosis and carrier detection of hemophilia B by using genomic amplification with transcripts sequencing].
    Liu J; Xiang H; Liu L
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):599-601, 638-9. PubMed ID: 8697074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene.
    Mukherjee S; Mukhopadhyay A; Chaudhuri K; Ray K
    Haemophilia; 2003 Mar; 9(2):187-92. PubMed ID: 12614370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.
    Green PM; Montandon AJ; Bentley DR; Ljung R; Nilsson IM; Giannelli F
    Nucleic Acids Res; 1990 Jun; 18(11):3227-31. PubMed ID: 1972560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene.
    Sommer SS
    FASEB J; 1992 Jul; 6(10):2767-74. PubMed ID: 1634040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
    Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
    Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a factor IX point mutation using SSCP analysis and direct sequencing.
    Demers DB; Odelberg SJ; Fisher LM
    Nucleic Acids Res; 1990 Sep; 18(18):5575. PubMed ID: 2216751
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers.
    Winship PR; Rees DJ; Alkan M
    Lancet; 1989 Mar; 1(8639):631-4. PubMed ID: 2564457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.
    Bottema CD; Ketterling RP; Ii S; Yoon HS; Phillips JA; Sommer SS
    Am J Hum Genet; 1991 Oct; 49(4):820-38. PubMed ID: 1680287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nine independent F9 mutations in the Mexican hemophilia B population: nonrandom recurrences of point mutation events in the human germline.
    Jaloma-Cruz AR; Scaringe WA; Drost JB; Roberts S; Li X; Barros-Núñez P; Figuera LE; Rivas F; Cantú JM; Sommer SS
    Hum Mutat; 2000 Jan; 15(1):116-7. PubMed ID: 10612837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic amplification with transcript sequencing.
    Stoflet ES; Koeberl DD; Sarkar G; Sommer SS
    Science; 1988 Jan; 239(4839):491-4. PubMed ID: 3340835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.